These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 27264544

  • 1. Application of flow cytometry for evaluating clinical prognosis and histopathological grade of human glioma.
    Lin YW, Tai SH, Chang CC, Chao LC, Wen MJ, Huang YH, Hung HY, Lee EJ.
    Neurol Res; 2016 Jul; 38(7):625-33. PubMed ID: 27264544
    [Abstract] [Full Text] [Related]

  • 2. The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas.
    Lin YW, Tai SH, Huang YH, Chang CC, Juan WS, Chao LC, Wen MJ, Hung YC, Lee EJ.
    Cytometry B Clin Cytom; 2015 Jul; 88(5):312-9. PubMed ID: 25408130
    [Abstract] [Full Text] [Related]

  • 3. Correlation of diffusion tensor and dynamic susceptibility contrast MRI with DNA ploidy and cell cycle analysis of gliomas.
    Zikou A, Alexiou GA, Vartholomatos G, Goussia A, Xydis VG, Kosta P, Voulgaris S, Kyritsis AP, Argyropoulou MI.
    Clin Neurol Neurosurg; 2015 Dec; 139():119-24. PubMed ID: 26432994
    [Abstract] [Full Text] [Related]

  • 4. The value of cell cycle analysis by propidium-iodine staining of CD56+ cells in pediatric brain tumors.
    Vartholomatos G, Alexiou GA, Stefanaki K, Lykoudis EG, Tseka G, Tzoufi M, Sfakianos G, Prodromou N.
    Clin Neurol Neurosurg; 2015 Jun; 133():70-4. PubMed ID: 25867234
    [Abstract] [Full Text] [Related]

  • 5. Intraoperative flow cytometry analysis of glioma tissue for rapid determination of tumor presence and its histopathological grade: clinical article.
    Shioyama T, Muragaki Y, Maruyama T, Komori T, Iseki H.
    J Neurosurg; 2013 Jun; 118(6):1232-8. PubMed ID: 23432426
    [Abstract] [Full Text] [Related]

  • 6. DNA content is associated with malignancy of intracranial neoplasms.
    Alexiou GA, Vartholomatos E, Goussia A, Dova L, Karamoutsios A, Fotakopoulos G, Kyritsis AP, Voulgaris S.
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1784-7. PubMed ID: 23683441
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
    Uematsu M, Ohsawa I, Aokage T, Nishimaki K, Matsumoto K, Takahashi H, Asoh S, Teramoto A, Ohta S.
    J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645
    [Abstract] [Full Text] [Related]

  • 10. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
    Tanaka K, Yamamoto Y, Maeda Y, Yamamoto H, Kudomi N, Kawai N, Toyohara J, Nishiyama Y.
    Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
    [Abstract] [Full Text] [Related]

  • 11. Radiomic features predict Ki-67 expression level and survival in lower grade gliomas.
    Li Y, Qian Z, Xu K, Wang K, Fan X, Li S, Liu X, Wang Y, Jiang T.
    J Neurooncol; 2017 Nov; 135(2):317-324. PubMed ID: 28900812
    [Abstract] [Full Text] [Related]

  • 12. Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control.
    Yuan Y, Xiang W, Yanhui L, Ruofei L, Shuang L, Yingjun F, Qiao Z, Yanwu Y, Qing M.
    Seizure; 2013 Dec; 22(10):877-81. PubMed ID: 23992787
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas.
    Taniguchi K, Wakabayashi T, Yoshida T, Mizuno M, Yoshikawa K, Kikuchi A, Nakashima N, Yoshida J.
    J Neurosurg; 1999 Sep; 91(3):477-82. PubMed ID: 10470824
    [Abstract] [Full Text] [Related]

  • 14. RIZ1: a potential tumor suppressor in glioma.
    Zhang C, Zhu Q, He H, Jiang L, Qiang Q, Hu L, Hu G, Jiang Y, Ding X, Lu Y.
    BMC Cancer; 2015 Dec 21; 15():990. PubMed ID: 26690953
    [Abstract] [Full Text] [Related]

  • 15. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D, Blanco C, Friedlander DR, Miller DC, Newcomb EW.
    Hum Pathol; 2003 Jan 21; 34(1):48-53. PubMed ID: 12605366
    [Abstract] [Full Text] [Related]

  • 16. Expression of cyclinD1 and Ki-67 proteins in gliomas and its clinical significance.
    Qu DW, Xu HS, Han XJ, Wang YL, Ouyang CJ.
    Eur Rev Med Pharmacol Sci; 2014 Jan 21; 18(4):516-9. PubMed ID: 24610618
    [Abstract] [Full Text] [Related]

  • 17. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
    Gabrovsky N, Georgieva M, Laleva M, Uzunov K, Miloshev G.
    Acta Neurochir (Wien); 2013 Aug 21; 155(8):1437-42. PubMed ID: 23812966
    [Abstract] [Full Text] [Related]

  • 18. The Role of Fast Cell Cycle Analysis in Pediatric Brain Tumors.
    Alexiou GA, Vartholomatos G, Stefanaki K, Lykoudis EG, Patereli A, Tseka G, Tzoufi M, Sfakianos G, Prodromou N.
    Pediatr Neurosurg; 2015 Aug 21; 50(5):257-63. PubMed ID: 26287721
    [Abstract] [Full Text] [Related]

  • 19. Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI.
    Jiang JS, Hua Y, Zhou XJ, Shen DD, Shi JL, Ge M, Geng QN, Jia ZZ.
    Acad Radiol; 2019 Sep 21; 26(9):1215-1221. PubMed ID: 30416002
    [Abstract] [Full Text] [Related]

  • 20. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A, Kulle B, Gadmar ØB, Josefsen R, Kumar T, Nakstad PH.
    Eur J Radiol; 2011 Nov 21; 80(2):462-70. PubMed ID: 20708868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.